[Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update].
López-San Román
A
A
Servicio de Gastroenterología, Hospital Ramón y Cajal, Madrid, Spain.
Obrador
A
A
Fortún
J
J
Muñoz
P
P
Gassull
M A
MA
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D009894:Opportunistic Infections / Q000517:prevention & control*; D014376:Tuberculosis / Q000517:prevention & control*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab